Skip to main content
Clinical Trials/NCT04977869
NCT04977869
Completed
Not Applicable

Safety and Efficacy Study of Remote Ischemic Conditioning Combined With Endovascular Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion of Anterior Circulation: A Multicenter, Randomized, Parallel-controlled Clinical Trial

Yi Yang1 site in 1 country498 target enrollmentAugust 26, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Ischemic Stroke
Sponsor
Yi Yang
Enrollment
498
Locations
1
Primary Endpoint
Proportion of patients with modified Rankin Scale (mRS) Score 0-2
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to determine the efficacy and safety of remote ischemic conditioning for patients of acute ischemic stroke who underwent endovascular thrombectomy due to large vessel occlusion of anterior circulation.

Detailed Description

In this study, 498 cases of ischemic stroke who undergo endovascular thrombectomy within 24 hours from the onset are included in 10 centers in China according to the principle of random, and parallel control. The experimental group receive basic treatment and remote ischemic conditioning for 200mmHg, 2 times per day for 7 consecutive days. The control group receive basic treatment and remote ischemic conditioning control for 60mmHg, 2 times per day for 7 consecutive days. Two groups will be followed up for 90 days to evaluate the efficacy and safety of remote ischemic conditioning for patients of acute ischemic stroke who underwent endovascular thrombectomy due to large vessel occlusion of anterior circulation.

Registry
clinicaltrials.gov
Start Date
August 26, 2021
End Date
September 16, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Yi Yang
Responsible Party
Sponsor Investigator
Principal Investigator

Yi Yang

Associated Dean of First Hospital of Jilin University

The First Hospital of Jilin University

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years, male or female
  • Diagnosis of acute ischemic stroke within 24 hours of symptom onset and underwent endovascular thrombectomy (EVT) adhering to current guidelines for large vessel occlusion in the anterior circulation (confirmed by computed tomography angiography or digital subtraction angiography)
  • Pre-EVT NIHSS ≥ 6
  • Premorbid mRS ≤ 2
  • Written informed consent obtained from the patient or legally responsible person

Exclusion Criteria

  • Contraindication of endovascular thrombectomy
  • Contraindication of remote ischemic conditioning, such as severe soft tissue injury, fracture, or vascular injury in the upper limb, acute or subacute venous thrombosis, arterial occlusive disease, and subclavian steal syndrome
  • Head CT showing cerebral hernia and midline displacement
  • Pregnancy or lactation
  • Previous remote ischemic conditioning therapy or similar treatment
  • Severe hepatic and renal dysfunction
  • Life expectancy of less than 3 months or inability to complete the study for other reasons
  • Unwilling to be followed up or poor compliance
  • Current or past participation in other clinical research, or participation in this study within 3 months prior to admission
  • Other conditions that the researchers think make the patient unsuitable for the study

Outcomes

Primary Outcomes

Proportion of patients with modified Rankin Scale (mRS) Score 0-2

Time Frame: 3 months

Proportion of patients with modified Rankin Scale (mRS) Score 0-2. Ranged from 0 to 6, a low value represents a better outcome.

Secondary Outcomes

  • National Institute of Health stroke scale (NIHSS) at 24 hours, 7 days (or discharge) after EVT.(24 hours, 7 days (or discharge))
  • Barthel Index (BI) at 24 hours, 7 days (or discharge) after EVT.(24 hours, 7 days (or discharge))
  • Proportion of patients with modified Rankin Scale (mRS) 0-1(90±3 days)
  • modified Rankin Scale (mRS) score distribution(90±3 days)
  • Recanalization rate within 7 days after EVT(7 days)
  • Early neurological deterioration at 7 days(7 days)
  • Frequency of Hemorrhagic transformation within 7 days(7 days)
  • Frequency of symptomatic intracranial hemorrhage within 7 days(7 days)
  • Death within 90 days(90±3 days)
  • Frequency of adverse events within 90 days(90±3 days)
  • Adverse events associated with remote ischemic conditioning within 90 days(90±3 days)
  • Frequency of serious adverse events within 90 days(90±3 days)

Study Sites (1)

Loading locations...

Similar Trials